Revenue Summary of GenMont Biotech Incorporation

GenMont Biotech Incorporation's latest annual revenue in 2023 was 318.01 Million TWD , down -13.71% from previous year.
GenMont Biotech Incorporation's latest quarterly revenue in 2024 Q2 was 94.18 Million TWD , down -19.1% from previous quarter.
GenMont Biotech Incorporation reported a annual revenue of 368.54 Million TWD in annual revenue 2022, down -13.88% from previous year.
GenMont Biotech Incorporation reported a annual revenue of 427.92 Million TWD in annual revenue 2021, up 31.59% from previous year.
GenMont Biotech Incorporation reported a quarterly revenue of 94.18 Million TWD for 2024 Q2, down -19.1% from previous quarter.
GenMont Biotech Incorporation reported a quarterly revenue of 87.93 Million TWD for 2023 Q2, up 10.43% from previous quarter.

Annual Revenue Chart of GenMont Biotech Incorporation (2023 - 2009)

Historical Annual Revenue of GenMont Biotech Incorporation (2023 - 2009)

Year	Revenue	Revenue Growth
2023	318.01 Million TWD	-13.71%
2022	368.54 Million TWD	-13.88%
2021	427.92 Million TWD	31.59%
2020	325.19 Million TWD	-6.08%
2019	346.24 Million TWD	-14.83%
2018	406.53 Million TWD	-26.48%
2017	552.94 Million TWD	2.25%
2016	540.78 Million TWD	1.13%
2015	534.71 Million TWD	-5.28%
2014	564.52 Million TWD	82.73%
2013	308.93 Million TWD	36.2%
2012	226.82 Million TWD	-20.75%
2011	286.21 Million TWD	-44.38%
2010	514.57 Million TWD	45.84%
2009	352.84 Million TWD	0.0%

Year	Revenue	Revenue Growth
2024 Q1	116.41 Million TWD	57.1%
2024 Q2	94.18 Million TWD	-19.1%
2023 Q2	87.93 Million TWD	10.43%
2023 Q3	76.35 Million TWD	-13.16%
2023 FY	318.01 Million TWD	-13.71%
2023 Q4	74.1 Million TWD	-2.96%
2023 Q1	79.62 Million TWD	-24.9%
2022 Q4	106.01 Million TWD	39.34%
2022 FY	368.54 Million TWD	-13.88%
2022 Q3	76.08 Million TWD	-20.32%
2022 Q2	95.49 Million TWD	4.99%
2022 Q1	90.95 Million TWD	-23.77%
2021 Q1	103.76 Million TWD	19.49%
2021 FY	427.92 Million TWD	31.59%
2021 Q4	119.32 Million TWD	13.24%
2021 Q3	105.36 Million TWD	5.92%
2021 Q2	99.47 Million TWD	-4.13%
2020 Q1	80.52 Million TWD	1.34%
2020 Q2	78.45 Million TWD	-2.57%
2020 Q3	79.37 Million TWD	1.17%
2020 FY	325.19 Million TWD	-6.08%
2020 Q4	86.84 Million TWD	9.41%
2019 FY	346.24 Million TWD	-14.83%
2019 Q1	91.08 Million TWD	-3.72%
2019 Q3	89.46 Million TWD	3.73%
2019 Q2	86.24 Million TWD	-5.32%
2019 Q4	79.45 Million TWD	-11.18%
2018 Q1	133.08 Million TWD	14.24%
2018 FY	406.53 Million TWD	-26.48%
2018 Q4	94.61 Million TWD	-20.09%
2018 Q3	118.39 Million TWD	21.54%
2018 Q2	97.41 Million TWD	-26.8%
2017 Q2	143.41 Million TWD	8.67%
2017 FY	552.94 Million TWD	2.25%
2017 Q4	116.49 Million TWD	-27.67%
2017 Q3	161.04 Million TWD	12.29%
2017 Q1	131.98 Million TWD	9.54%
2016 FY	540.78 Million TWD	1.13%
2016 Q4	120.49 Million TWD	-17.61%
2016 Q3	146.23 Million TWD	1.2%
2016 Q2	144.49 Million TWD	11.53%
2016 Q1	129.55 Million TWD	4.3%
2015 FY	534.71 Million TWD	-5.28%
2015 Q1	120.91 Million TWD	14.12%
2015 Q2	126.3 Million TWD	4.46%
2015 Q3	163.28 Million TWD	29.29%
2015 Q4	124.22 Million TWD	-23.93%
2014 FY	564.52 Million TWD	82.73%
2014 Q3	176.27 Million TWD	7.9%
2014 Q1	118.93 Million TWD	71.82%
2014 Q4	105.95 Million TWD	-39.89%
2014 Q2	163.36 Million TWD	37.35%
2013 Q4	69.22 Million TWD	-4.46%
2013 FY	308.93 Million TWD	36.2%
2013 Q2	91.45 Million TWD	20.64%
2013 Q1	75.8 Million TWD	25.42%
2013 Q3	72.45 Million TWD	-20.78%
2012 Q4	60.44 Million TWD	9.13%
2012 Q2	61.59 Million TWD	24.72%
2012 Q1	49.38 Million TWD	-39.86%
2012 Q3	55.38 Million TWD	-10.08%
2012 FY	226.82 Million TWD	-20.75%
2011 Q2	59.55 Million TWD	-36.55%
2011 Q1	93.85 Million TWD	-34.45%
2011 FY	286.21 Million TWD	-44.38%
2011 Q4	82.13 Million TWD	62.08%
2011 Q3	50.67 Million TWD	-14.91%
2010 Q2	123.96 Million TWD	-7.63%
2010 Q1	134.2 Million TWD	0.0%
2010 FY	514.57 Million TWD	45.84%
2010 Q4	143.19 Million TWD	26.49%
2010 Q3	113.2 Million TWD	-8.68%
2009 FY	352.84 Million TWD	0.0%

Peer Revenue Comparison of GenMont Biotech Incorporation

Name	Revenue	Revenue Difference
Apex Biotechnology Corp.	1.67 Billion TWD	81.031%
Sinphar Pharmaceutical Co.,Ltd.	2.96 Billion TWD	89.267%
Panion & Bf Biotech Inc.	1.88 Billion TWD	83.101%
Chunghwa Chemical Synthesis & Biotech Co., Ltd.	2.08 Billion TWD	84.758%
Abnova (Taiwan) Corporation	382.05 Million TWD	16.761%
Adimmune Corporation	1.78 Billion TWD	82.185%
Tanvex BioPharma, Inc.	61.41 Million TWD	-417.847%
Polaris Group	7.48 Million TWD	-4150.969%
Energenesis Biomedical CO.,LTD.	7.15 Million TWD	-4342.791%
UnicoCell Biomed Co., Ltd.	24.58 Million TWD	-1193.322%
PELL Bio-Med Technology Co. Ltd.	18.03 Million TWD	-1663.517%

Global Stocks Search

GenMont Biotech Incorporation (3164.TW)

Revenue Summary of GenMont Biotech Incorporation

Annual Revenue Chart of GenMont Biotech Incorporation (2023 - 2009)

Historical Annual Revenue of GenMont Biotech Incorporation (2023 - 2009)

Peer Revenue Comparison of GenMont Biotech Incorporation